David B. Matias
InvestorFounder, CPA at Vodia Ventures · Board director at Cryoocyte · Board director at RxWare
New York City and Boston
Find your path to David
245 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.
About
David founded the Vodia companies in 2004 and leads Vodia Capital, a wealth management firm, focusing on socially oriented investing across digital health, fintech, and water infrastructure. He was previously a CPA at Coopers & Lybrand Boston and a partner at Mitchell Madison Group, and holds degrees from Amherst College and MIT Sloan.
Board director at Cryoocyte
Intro paths
In turn, David can intro founders to Cryoocyte's investors below.
Cryoocyte's investors · 2
Board director at RxWare
Intro paths
In turn, David can intro founders to RxWare's investors below.
RxWare's investors · 3
Experience
- Robertson StephensManaging Director, Principalcurrent2022 — presentBoston, Massachusetts, United States
- Vodia Ventures GroupManaging Partnercurrent2013 — presentConcord, Massachusetts, United States
- Vodia Capital, LLCManaging Principal2004 — 2022Boston and NYC
- Congregation Kerem ShalomTreasurer2012 — 2017Concord, Massachusetts, United States
- American Management AssociationFaculty2001 — 2008New York City
- MIT Sloan School of ManagementConsultant2001 — 2004Cambridge, Massachusetts, United States
- Career BreakPersonal goal pursuit2001 — 2004Carlisle, Massachusetts, United States
- Mitchell Madison Group/MarchFirstPartner1995 — 2001New York, United States & London
- Silver Oak Partners / Silver Oak SolutionsChief Financial Officer2000Boston, Massachusetts, United States
- PricewaterhouseCoopersSenior Associate1990 — 1993
Skills & more
+8 more
Mergers & AcquisitionsDue DiligenceHedge FundsInvestmentsAlternative InvestmentsAsset ManagementRisk ManagementManagement Consulting- Series 65 — FINRA
- Certified Public Accountant — AICPA
From David's professional profile.
Deals · 8
CryoocyteBoard seat
via Vodia Ventures · filed Oct 2017 · $7.4M raise
UpriserBoard seat
via Vodia Ventures · filed Jun 2015 · $800K raise
DemandQSolo GP
via Vodia Ventures
EctoSolo GP
via Vodia Ventures
BuzzSolo GP
via Vodia Ventures
GlowSolo GP
via Vodia Ventures
unnamed imaging platformSolo GP
via Vodia Ventures
unnamed tech support platformSolo GP
via Vodia Ventures
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Colleagues at Vodia Ventures
Frequently asked questions
- Who is David B. Matias?
- David founded the Vodia companies in 2004 and leads Vodia Capital, a wealth management firm, focusing on socially oriented investing across digital health, fintech, and water infrastructure. He was previously a CPA at Coopers & Lybrand Boston and a partner at Mitchell Madison Group, and holds degrees from Amherst College and MIT Sloan.
- Where does David B. Matias work?
- David B. Matias is Founder, CPA at Vodia Ventures and Board director at Cryoocyte and Board director at RxWare.
- What boards does David B. Matias sit on?
- David B. Matias holds tracked board seats at Cryoocyte, Upriser.
- Where did David B. Matias go to school?
- David B. Matias studied at MIT Sloan School of Management (SM, Financial Engineering); The Jewish Theological Seminary (JTS) (Master's degree, Bible/Biblical Studies); Amherst College (Bachelor of Arts, Political Science).
Same school
Also attended MIT Sloan School of Management774
+ 768 more
Also attended The Jewish Theological Seminary (JTS)5
Also attended Amherst College158
+ 152 more
Also attended Concord Academy7
+ 1 more
Shared employers
Also worked at Robertson Stephens47
+ 41 more
Also worked at American Management Association2
Also worked at MIT Sloan School of Management138
.avif)
+ 132 more
Also worked at PricewaterhouseCoopers1,861
+ 1,855 more